HeadlinesNews

COVID-19 vaccine has mild side effect, cases decline sharply , deaths rise in Nigeria – FG

0

COVID-19 vaccine has mild side effect, cases decline sharply , deaths rise in Nigeria – FG

 

The  AstraZeneca COVID-19 vaccine has been confirmed to have nothing but a mild side effect.

Thee Minister of Health, Osagie Ehanire, who made the disclosure, explained that those vaccinated may experience “small pain” in the area it was injected.

Ehanire disclosed this after the vaccination of President Muhammadu Buhari and his Vice, Yemi Osinbajo at the State House, yesterday.

He however, stated that the administration of the COVID-19 vaccine is expected to be painless.

“The process itself is simple. We are using a narrow gauge syringe, which will be very painless, and it is a small quantity that is injected into the muscle of your upper arm.

“The after-effects, as we know so far, are mild. There can be a small pain in the area where it was injected,” he said.

Meanwhile, daily COVID-19 cases in Nigeria on Saturday, took another deep plunge  falling from 371 on Friday to a very new low of 195 with the death toll in the last 24 hours jumping from three to 10.

According to the data published by NCDC early Sunday, the deaths were recorded in three states and the capital of Abuja.

Edo led with four fatalities to send its death toll to 180.

Abuja logged three and now has 153 deaths overall.

Kano state recorded two new deaths and its overall toll is now 107.

Lagos accounted for the last of the 10 deaths, which increased its cumulative toll to 415.

While confirmed cases of COVID-19 in Nigeria inched to 158, 237, the discharged also increased to 137,645.

Active cases fell below 19,000 to 18, 628.

On the latest confirmed cases, the NCDC said they were reported by 16 states and Abuja.

Lagos reported 70 cases, the highest for the day.

© 2021, maritimemag. All rights reserved.

Expatriates, Nigerians kidnapped by pirates regain freedom

Previous article

Lagos night clubs, lounges, event centres breach  coronavirus protocols

Next article

You may also like

Comments

Comments are closed.

More in Headlines